作者
Christopher D Doern
发表日期
2014/12
来源
Journal of clinical microbiology
卷号
52
期号
12
页码范围
4124-4128
出版商
American Society for Microbiology
简介
In this age of emerging antibiotic resistance, limited therapeutic options exist for treating multidrug-resistant organisms. Combination therapy is commonly employed to manage these infections despite little laboratory guidance as to the efficacy of this approach. Synergy testing methods have been used to assess the interaction of antibiotic combinations in vitro. This review will discuss the four primary methods used to assess synergy, as well as the data that exist for testing of cystic fibrosis. In the final analysis, this review concludes that there is not enough evidence to endorse synergy testing for routine clinical use.
引用总数
2014201520162017201820192020202120222023202448102230525669676025